Cytochrome P-450 CYP1A2 Inducers (strength unknown)
DBCAT004504Pharmacologic class
Inducers of the CYP1A2 enzyme with no identified strength of induction. A DrugBank category of 66 drugs. 56 of them are approved.
- Also known as
- Cytochrome P-450 CYP1A2 Inducers (unknown strength) · Unclassified CYP1A2 inducers
- Drugs
- Almonertinib
- Armodafinil
- Avacopan
- beta-Naphthoflavone
- Camizestrant
- Cannabidiol
- Capsaicin
- Defactinib
- Dovitinib
- Ensitrelvir
- Fexinidazole
- Fosphenytoin
- Givinostat
- Griseofulvin
- Insulin argine
- Insulin aspart
- Insulin beef
- Insulin degludec
- Insulin detemir
- Insulin glargine
- Insulin glulisine
- Insulin human
- Insulin lispro
- Insulin peglispro
- Insulin pork
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP1A2 Inducers (strength unknown) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account